Qinli Zhang Selected Research

Aluminum

2/2022	Necrostatin-1 Relieves Learning and Memory Deficits in a Zebrafish Model of Alzheimer's Disease Induced by Aluminum.
1/2022	Aluminum inhibits non-amyloid pathways via retinoic acid receptor.
5/2021	Increased aluminum and lithium and decreased zinc levels in plasma is related to cognitive impairment in workers at an aluminum factory in China: A cross-sectional study.
4/2021	Involvement of Mitophagy in Aluminum Oxide Nanoparticle-Induced Impairment of Learning and Memory in Mice.
3/2021	Effect of aluminum combined with ApoEε4 on Tau phosphorylation and Aβ deposition.
1/2021	miR-29a/b1 Regulates BACE1 in Aluminum-Induced Aβ Deposition in Vitro.
8/2020	Aluminum-Induced Cognitive Impairment and PI3K/Akt/mTOR Signaling Pathway Involvement in Occupational Aluminum Workers.
7/2015	The Relationship Between Cognitive Impairment and Global DNA Methylation Decrease Among Aluminum Potroom Workers.
7/2014	Effects of aluminium on β-amyloid (1-42) and secretases (APP-cleaving enzymes) in rat brain.
2/2014	Cognitive disorders and tau-protein expression among retired aluminum smelting workers.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qinli Zhang Research Topics

Disease

7	Cognitive Dysfunction 09/2022 - 01/2014
6	Alzheimer Disease (Alzheimer's Disease) 02/2022 - 01/2014
4	Memory Disorders (Memory Loss) 02/2022 - 01/2015
2	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2021 - 01/2014
2	Necrosis 04/2021 - 11/2014
1	Neoplasms (Cancer) 04/2021
1	Congenital Abnormalities (Deformity) 01/2017
1	Alcoholism (Alcohol Abuse) 07/2015
1	Amyloid Plaque 07/2014
1	Body Weight (Weight, Body) 07/2014
1	Brain Ischemia (Cerebral Ischemia) 05/2008
1	Glioma (Gliomas) 05/2008
1	Ischemia 05/2008

Drug/Important Bio-Agent (IBA)

12	AluminumIBA 02/2022 - 05/2008
4	Proteins (Proteins, Gene)FDA Link 04/2021 - 05/2008
2	Aluminum Oxide (Sapphire)IBA 09/2022 - 01/2017
2	Small Interfering RNA (siRNA)IBA 01/2014 - 05/2008
1	necrostatin-1IBA 02/2022
1	LithiumIBA 05/2021
1	IonsIBA 05/2021
1	MetalsIBA 05/2021
1	ZincIBA 05/2021
1	Beclin-1IBA 04/2021
1	Autophagy-Related ProteinsIBA 04/2021
1	Saline SolutionIBA 04/2021
1	Amyloid beta-PeptidesIBA 01/2021
1	Sirolimus (Rapamycin)FDA Link 08/2020
1	Ethanol (Ethyl Alcohol)IBA 07/2015
1	Factor XI (Plasma Thromboplastin Antecedent)IBA 07/2015
1	Apolipoprotein E4IBA 01/2015
1	Sincalide FDA Link 11/2014
1	Amyloid (Amyloid Fibrils)IBA 07/2014
1	tau Proteins (tau Protein)IBA 02/2014
1	CaspasesIBA 01/2014
1	salicylhydroxamic acid (SHAM)IBA 05/2008
1	Nylons (Nylon)IBA 05/2008
1	Messenger RNA (mRNA)IBA 05/2008

Therapy/Procedure

1	Intraperitoneal Injections 07/2014